| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |